0001567619-19-006067.txt : 20190304
0001567619-19-006067.hdr.sgml : 20190304
20190304184032
ACCESSION NUMBER: 0001567619-19-006067
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190228
FILED AS OF DATE: 20190304
DATE AS OF CHANGE: 20190304
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Havey Adam
CENTRAL INDEX KEY: 0001514588
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33137
FILM NUMBER: 19655875
MAIL ADDRESS:
STREET 1: 2273 RESEARCH BLVD SUITE 400
CITY: ROCKVILLE
STATE: MD
ZIP: 20853
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Emergent BioSolutions Inc.
CENTRAL INDEX KEY: 0001367644
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 141902018
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 PROFESSIONAL DR, SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
BUSINESS PHONE: 240-631-3200
MAIL ADDRESS:
STREET 1: 400 PROFESSIONAL DR, SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
4
1
doc1.xml
FORM 4
X0306
4
2019-02-28
0
0001367644
Emergent BioSolutions Inc.
EBS
0001514588
Havey Adam
400 PROFESSIONAL DR, SUITE 400
GAITHERSBURG
MD
20879
0
1
0
0
EVP, Business Operations
Common Stock
2019-02-28
4
S
0
1019
57.9218
D
36694
D
Common Stock
2019-03-01
4
S
0
2024
58.20
D
34670
D
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey.
The price reported is the weighted average price. These shares were sold in multiple transactions at prices ranging from $57.52 to $58.49, inclusive.
/s/ S. Scott Lieberman, Attorney-in-fact
2019-03-04